Al-Aoukaty A, Rolstad B, Maghazachi AA (1999) Recruitment of pleckstrin and phosphoinositide 3-kinase gamma into the cell membranes, and their association with G beta gamma after activation of NK cells with chemokines. J Immunol 162:3249–3255 CASPubMed Google Scholar
Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard O, Caroni P (1998) Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature 393:805–809 ArticleCASPubMed Google Scholar
Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, Kooistra T, Fingerle-Rowson G, Ghezzi P, Kleemann R, McColl SR, Bucala R, Hickey MJ, Weber C (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13:587–596 ArticleCASPubMed Google Scholar
Braunersreuther V, Zernecke A, Arnaud C, Liehn EA, Steffens S, Shagdarsuren E, Bidzhekov K, Burger F, Pelli G, Luckow B, Mach F, Weber C (2007) Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol 27:373–379 ArticleCASPubMed Google Scholar
Dunaeva M, Voo S, van Oosterhoud C, Waltenberger J (2010) Sonic hedgehog is a potent chemoattractant for human monocytes: diabetes mellitus inhibits Sonic hedgehog-induced monocyte chemotaxis. Basic Res Cardiol 105:61–71 ArticleCASPubMed Google Scholar
Fontaine C, Rigamonti E, Nohara A, Gervois P, Teissier E, Fruchart JC, Staels B, Chinetti-Gbaguidi G (2007) Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages. Circ Res 101:40–49 ArticleCASPubMed Google Scholar
Goetze S, Eilers F, Bungenstock A, Kintscher U, Stawowy P, Blaschke F, Graf K, Law RE, Fleck E, Gräfe M (2002) PPAR activators inhibit endothelial cell migration by targeting Akt. Biochem Biophys Res Commun 293:1431–1437 ArticleCASPubMed Google Scholar
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685–1695 ArticleCASPubMed Google Scholar
Heller EA, Liu E, Tager AM, Yuan Q, Lin AY, Ahluwalia N, Jones K, Koehn SL, Lok VM, Aikawa E, Moore KJ, Luster AD, Gerszten RE (2006) Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation 113:2301–2312 ArticleCASPubMed Google Scholar
Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9:213–219 ArticleCASPubMed Google Scholar
Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, Chen M, Noh G, Goodman J, Hagger GN, Tran J, Tippin TK, Wang X, Lusis AJ, Hsueh WA, Law RE, Collins JL, Willson TM, Tontonoz P (2002) Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA 99:7604–7609 ArticleCASPubMed Google Scholar
Lund EG, Menke JG, Sparrow CP (2003) Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis. Arterioscler Thromb Vasc Biol 23:1169–1177 ArticleCASPubMed Google Scholar
Maggiolini M, Picard D (2010) The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 204:105–114 ArticleCASPubMed Google Scholar
Ryu JW, Hong KH, Maeng JH, Kim JB, Ko J, Park JY, Lee KU, Hong MK, Park SW, Kim YH, Han KH (2004) Overexpression of uncoupling protein 2 in THP1 monocytes inhibits beta2 integrin-mediated firm adhesion and transendothelial migration. Arterioscler Thromb Vasc Biol 24:864–870 ArticleCASPubMed Google Scholar
Sanchez-Madrid F, del Pozo MA (1999) Leukocyte polarization in cell migration and immune interactions. EMBO J 18:501–511 ArticleCASPubMed Google Scholar
Serrador JM, Nieto M, Sanchez-Madrid F (1999) Cytoskeletal rearrangement during migration and activation of T lymphocytes. Trends Cell Biol 9:228–233 ArticleCASPubMed Google Scholar
Stenson BM, Rydén M, Steffensen KR, Wåhlén K, Pettersson AT, Jocken JW, Arner P, Laurencikiene J (2009) Activation of liver X receptor (LXR) regulates substrate oxidation in white adipocytes. Endocrinology 150:4104–4113 ArticleCASPubMed Google Scholar
Tangirala RK, Bischoff ED, Joseph SB, Wagner BL, Walczak R, Laffitte BA, Daige CL, Thomas D, Heyman RA, Mangelsdorf DJ, Wang X, Lusis AJ, Tontonoz P, Schulman IG (2002) Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci USA 99:11896–11901 ArticleCASPubMed Google Scholar
Tontonoz P, Mangelsdorf DJ (2003) Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 17:985–993 ArticleCASPubMed Google Scholar
Veillard NR, Steffens S, Pelli G, Lu B, Kwak BR, Gerard C, Charo IF, Mach F (2005) Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation 112:870–878 ArticleCASPubMed Google Scholar
Walcher D, Kümmel A, Kehrle B, Bach H, Betz S, Durst R, Grüb M, Hombach V, Marx N (2006) Liver-X-receptor activation reduces proinflammatory cytokine expression in human CD4 positive lymphocytes. Arterioscler Thromb Vasc Biol 26:1022–1028 ArticleCASPubMed Google Scholar
Walcher D, Aleksic M, Jerg V, Hombach V, Zieske A, Homma S, Strong J, Marx N (2004) C-peptide induces chemotaxis of human CD4-positive lymphocytes—involvement of pertussis toxin-sensitive G-proteins and PI 3-kinase. Diabetes 53:1664–1670 ArticleCASPubMed Google Scholar
Walcher D, Hess K, Heinz P, Vasic D, Petscher K, Kintscher U, Clemenz M, Raps K, Hombach V, Marx N (2008) Telmisartan inhibits CD4-positive lymphocyte migration independent of the angiotensin-1 receptor via PPARgamma. Hypertension 51:259–266 ArticleCASPubMed Google Scholar
Zelcer N, Hong C, Boyadjian R, Tontonoz P (2009) LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 325:100–104 ArticleCASPubMed Google Scholar
Zernecke A, Weber C (2005) Inflammatory mediators in atherosclerotic vascular disease. Basic Res Cardiol 100:93–101 ArticleCASPubMed Google Scholar